Prognostic Tumor-Infiltrating Immune Cell Score in Endometrial Carcinoma
Tumor-infiltrating Immune Cell Score as an effective and independent prognostic tool for patients with EC.
Read More
Search Physician’s Weekly
Search for articles, editorials, meeting coverage, podcasts, and more
Showing 1 - 20 of 112 results for 'endometrial carcinoma '
ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma.
The standard surgical treatment of endometrial carcinoma (EC) consisting of total hysterectomy...
Read More
Diagnosis of Glioblastoma Changed to Metastasis from Endometrial Carcinoma After Next-Gen DNA Sequencing
Endometrial cancer is undoubtedly the most prevalent gynecologic cancer in the United States of...
Read More
A Longitudinal Cohort Study to Determine the Efficacy Sentinel Lymph Node Mapping in High-Risk Patients Diagnosed with Endometrial Carcinoma.
It was unclear how effective wat is to map sentinel lymph nodes (SLN) for high-risk endometrial...
Read More
A Study on the Survival and Mortality of Endometrial Carcinoma on Patients and Whether Steps Can Be Taken to Improve Survival Rates
The title of the most prevalent gynecologic cancer in the United States is held by endometrial...
Read More
The Obstacles That Are Faced Due to Singling Out Human Epidermal Growth Factor Receptor 2 (HER2) in Endometrial Carcinoma
In the United States, over 50,000 women get diagnosed with endometrial cancer every year, making...
Read More
In Type I Endometrial Carcinomas, ALDH1 Expression Predicts The Development of Premalignant Lesions To Malignancy
Unopposed estrogen stimulation is hypothesized to cause endometrial hyperplasia, which precedes...
Read MoreOvarian metastasis risk factors in endometrial carcinoma: A systematic review and meta-analysis.
To investigate the incidence of ovarian metastasis in endometrial carcinoma (EC) and analyze its risk factors and provide a theoretical basis for whether retention of the ovary in patients with EC.A systematic search using...
Read More
PTEN protein expression has role in predicting disease-free-interval in endometrioid endometrial carcinoma.
To determine the significance of tumour PTEN protein expression in endometrioid endometrial...
Read MoreAdvertisement
Sentinel Nodal Metastasis Detection in Endometrial Carcinoma With Microcystic, Elongated, and Fragmented (MELF) Pattern by Cytokeratin Immunostaining.
The microcystic, elongated, and fragmented (MELF) pattern of myoinvasion in endometrial carcinoma...
Read More
BarH-like homeobox 1 induces the progression of cell malignant phenotype in endometrial carcinoma through the regulation of ERK/MEK signaling pathway.
The aim of this article was to assess whether and how BARX1 affects the progression of malignant...
Read More
Robotic-assisted laparoscopic hysterectomy for endometrial hyperplasia or grade 1 endometrial adenocarcinoma: a ten-year, single centre experience.
To describe the outcomes of patients undergoing robotic-assisted laparoscopic hysterectomy for...
Read MoreImplementation of endometrial cancer molecular subtyping into a hybrid community-academic practice.
We sought to confirm utility of our institution’s modified Proactive Molecular Risk Classifier for Endometrial Cancer protocol in our daily practice, which includes mismatch repair (MMR), p53, and L1 cell adhesion molecule...
Read More
Rates of Endometrial Cancer Vary for U.S., Caribbean Black Women
MONDAY, June 26, 2023 (HealthDay News) — Caribbean Black women have lower rates of...
Read More
Utility of TRPS1 immunohistochemistry in confirming breast carcinoma: Emphasis on staining in triple-negative breast cancers and gynecologic tumors.
Our aim was to explore the performance of TRPS1 as an immunohistochemical diagnostic marker; find...
Read MoreHER2 in uterine serous carcinoma: Current state and clinical perspectives.
Uterine cancer has the highest incidence and the second-highest mortality rate among gynecologic malignancies in the United States. Although uterine serous carcinoma (USC) represents less than 10% of endometrial carcinomas, it...
Read More
Mucinous carcinoma originating from uterine adenomyosis: a case report.
Uterine adenomyosis is rarely a precursor of malignant tumors, but the most frequent histological...
Read More
Endometrial Cancer Immunotherapy: Facts and Hopes
The following is a summary of “Facts and Hopes in Immunotherapy of Endometrial Cancer”...
Read More
High Endometrial Cancers with Hypermethylated MLH1 Promoter Have Distinct Molecular and Clinical Profiles
Microsatellite instability-high (MSI-H) endometrial carcinomas are underpinned by distinct...
Read More
Letrozole and abemaciclib in estrogen receptor–positive recurrent endometrial cancer
1. Almost half of patients (47%) had either an objective response or had progression free survival...
Read More